SG10201809286XA - Biologically active peptides - Google Patents

Biologically active peptides

Info

Publication number
SG10201809286XA
SG10201809286XA SG10201809286XA SG10201809286XA SG10201809286XA SG 10201809286X A SG10201809286X A SG 10201809286XA SG 10201809286X A SG10201809286X A SG 10201809286XA SG 10201809286X A SG10201809286X A SG 10201809286XA SG 10201809286X A SG10201809286X A SG 10201809286XA
Authority
SG
Singapore
Prior art keywords
biologically active
active peptides
peptides
biologically
active
Prior art date
Application number
SG10201809286XA
Inventor
Friedrich Scheiflinger
Michael Dockal
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of SG10201809286XA publication Critical patent/SG10201809286XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

No Suitable Figure]
SG10201809286XA 2008-04-17 2009-04-16 Biologically active peptides SG10201809286XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US932608P 2008-04-17 2008-04-17
US11305508P 2008-11-10 2008-11-10

Publications (1)

Publication Number Publication Date
SG10201809286XA true SG10201809286XA (en) 2018-11-29

Family

ID=40887122

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201809286XA SG10201809286XA (en) 2008-04-17 2009-04-16 Biologically active peptides
SG10201608071YA SG10201608071YA (en) 2008-04-17 2009-04-16 Biologically active peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201608071YA SG10201608071YA (en) 2008-04-17 2009-04-16 Biologically active peptides

Country Status (19)

Country Link
US (6) US8563688B2 (en)
EP (2) EP3115370B1 (en)
JP (3) JP6038452B2 (en)
KR (2) KR101434712B1 (en)
CN (2) CN102007140B (en)
AR (1) AR071478A1 (en)
AU (1) AU2009244635B2 (en)
BR (1) BRPI0911203A2 (en)
CA (1) CA2721694C (en)
DK (2) DK2279200T3 (en)
ES (2) ES2739676T3 (en)
HK (2) HK1154255A1 (en)
MX (1) MX2010011397A (en)
NZ (1) NZ588200A (en)
PL (1) PL2279200T3 (en)
PT (1) PT2279200T (en)
SG (2) SG10201809286XA (en)
TW (2) TWI541020B (en)
WO (1) WO2009137256A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI541020B (en) * 2008-04-17 2016-07-11 巴克斯歐塔公司 Biologically active peptides
AU2010290077C1 (en) 2009-08-24 2015-12-03 Bioverativ Therapeutics Inc. Coagulation factor IX compositions and methods of making and using same
CN103262532B (en) 2010-07-19 2018-03-09 杜比实验室特许公司 Enhancement Method for sampled and multiplexed image and video data
PL2717898T3 (en) 2011-06-10 2019-06-28 Bioverativ Therapeutics Inc. Pro-coagulant compounds and methods of use thereof
EP3549953A1 (en) 2012-02-15 2019-10-09 Bioverativ Therapeutics Inc. Recombinant factor viii proteins
ES2771208T3 (en) 2012-02-15 2020-07-06 Bioverativ Therapeutics Inc Factor VIII compositions and methods of preparation and use thereof
JP6246894B2 (en) * 2013-06-11 2017-12-13 シージェイ チェイルジェダング コーポレイション Microorganism producing L-isoleucine and method for producing L-isoleucine using the same
WO2015023891A2 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Factor viii-xten fusions and uses thereof
WO2015023894A1 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Recombinant factor viii proteins
EP3065769A4 (en) 2013-11-08 2017-05-31 Biogen MA Inc. Procoagulant fusion compound
US20160039876A1 (en) 2014-03-28 2016-02-11 Claresa Levetan Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide
JP6484468B2 (en) * 2014-06-03 2019-03-13 ＡｖａｎＳｔｒａｔｅ株式会社 Glass plate manufacturing method and glass plate manufacturing apparatus
GB201410507D0 (en) * 2014-06-12 2014-07-30 Univ Bath Drug delivery enhancement agents
EA201890423A1 (en) 2015-08-03 2018-07-31 Биовератив Терапьютикс Инк. SLIGHT PROTEINS OF THE FACTOR IX, METHODS OF THEIR RECEPTION AND APPLICATION
US11111271B2 (en) 2016-09-28 2021-09-07 Cohbar, Inc. Therapeutic peptides
AU2018215092A1 (en) 2017-01-31 2019-08-29 Bioverativ Therapeutics Inc. Factor IX fusion proteins and methods of making and using same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) * 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
IT1190891B (en) 1982-06-24 1988-02-24 Anic Spa METHOD FOR SOLID PHASE SYNTHESIS OF RETROINVERTED POLYPEPTIDES
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
JPH0725794B2 (en) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 Novel peptide
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US6037452A (en) * 1992-04-10 2000-03-14 Alpha Therapeutic Corporation Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
BR9405798A (en) 1993-02-22 1995-12-12 Vivorx Pharmaceuticals Inc Methods for in vivo release of biological material and useful compositions thereof
WO1996021024A1 (en) * 1994-12-30 1996-07-11 Asgrow Seed Company Papaya ringspot virus replicase gene
US5532153A (en) * 1995-03-23 1996-07-02 New England Biolabs, Inc. Method for cloning and producing the SacI restriction endonuclease
US7279548B2 (en) * 1996-04-03 2007-10-09 Cytogen Corporation Identification and isolation of novel polypeptides having WW domains and methods of using same
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7109170B2 (en) 1999-06-16 2006-09-19 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
US6624289B1 (en) * 1999-06-16 2003-09-23 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
JP2003503426A (en) 1999-07-02 2003-01-28 ジェネンテック・インコーポレーテッド FVIIa antagonist
AT411997B (en) 1999-09-14 2004-08-26 Baxter Ag FACTOR IX / FACTOR IXA ACTIVATING ANTIBODIES AND ANTIBODY DERIVATIVES
WO2001039799A2 (en) * 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Passive desensitization
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2
EP1385872A4 (en) * 2001-05-11 2004-12-15 Res Dev Foundation Inhibitors of receptor activator of nf-kappa b and uses thereof
FR2830865B1 (en) * 2001-10-17 2004-10-22 Centre Nat Rech Scient PEPTIDE LURES FOR THE PREPARATION OF MEDICINES FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES, OR OF DISORDERS RELATED TO THE APPEARANCE OF ANTIBODIES DIRECTED AGAINST EXOGENOUS PROTEINS
US20060204503A1 (en) * 2005-01-31 2006-09-14 Biogen Idec Ma Inc. Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors
WO2007065691A2 (en) * 2005-12-07 2007-06-14 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
KR20080087148A (en) 2006-01-04 2008-09-30 두-쿱 테크놀로지스 리미티드 Cryoprotective compositions and methods of using same
TWI541020B (en) * 2008-04-17 2016-07-11 巴克斯歐塔公司 Biologically active peptides

Also Published As

Publication number Publication date
TWI541020B (en) 2016-07-11
KR20130112959A (en) 2013-10-14
ES2739676T3 (en) 2020-02-03
JP2014074052A (en) 2014-04-24
DK3115370T3 (en) 2019-07-29
EP2279200B1 (en) 2016-07-13
US20190225648A1 (en) 2019-07-25
US10822376B2 (en) 2020-11-03
MX2010011397A (en) 2010-11-12
CN105524163A (en) 2016-04-27
EP3115370A1 (en) 2017-01-11
EP3115370B1 (en) 2019-06-26
TW200944226A (en) 2009-11-01
HK1154255A1 (en) 2012-04-13
EP2279200A1 (en) 2011-02-02
ES2594706T3 (en) 2016-12-22
NZ588200A (en) 2012-11-30
US20160060295A1 (en) 2016-03-03
US20170174724A1 (en) 2017-06-22
US10287319B2 (en) 2019-05-14
US8563688B2 (en) 2013-10-22
US20100022445A1 (en) 2010-01-28
JP5977223B2 (en) 2016-08-24
CA2721694C (en) 2018-11-06
JP2017019797A (en) 2017-01-26
US8822638B2 (en) 2014-09-02
DK2279200T3 (en) 2016-08-22
AR071478A1 (en) 2010-06-23
TWI573806B (en) 2017-03-11
WO2009137256A1 (en) 2009-11-12
CA2721694A1 (en) 2009-11-12
US20120077749A1 (en) 2012-03-29
PL2279200T3 (en) 2017-08-31
CN102007140B (en) 2016-02-24
SG10201608071YA (en) 2016-11-29
US20150038676A1 (en) 2015-02-05
AU2009244635A1 (en) 2009-11-12
BRPI0911203A2 (en) 2016-07-05
KR101606248B1 (en) 2016-03-24
JP2011518179A (en) 2011-06-23
JP6038452B2 (en) 2016-12-07
US9598464B2 (en) 2017-03-21
TW201443085A (en) 2014-11-16
AU2009244635B2 (en) 2012-04-19
KR20110005873A (en) 2011-01-19
KR101434712B1 (en) 2014-10-01
CN102007140A (en) 2011-04-06
PT2279200T (en) 2016-10-12
HK1223946A1 (en) 2017-08-11
US9206234B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
SG10201809286XA (en) Biologically active peptides
EP2310407A4 (en) Biologically active peptidomimetic macrocycles
IL201233A0 (en) Enhanced active current location tracker
IL197444A0 (en) Cell culture improvements
EP2275440A4 (en) Growth factor-mimicking peptides and uses thereof
GB2460685B (en) An inclusive chair
HK1164867A1 (en) Biologically active amides
EP2456365A4 (en) Biologically active sutures for regenerative medicine
IL212123A0 (en) Method of making biologically active alpha-beta peptides
ZA201007436B (en) Encapsulation of biologically active agents
GB0820629D0 (en) Biocompatible electrode
HK1213916A1 (en) Biologically active c-terminal arginine-containing peptides c-
UA107476C2 (en) Pharmaceutical substance on the basis of mitochondrially addressed compounds
GB0800524D0 (en) Cell culture system
GB2473401B (en) Recombinant bacteria for producing deoxyviolacein and uses thereof
EP2557088A4 (en) Physiologically active peptides
GB0606671D0 (en) Cell Culture
ZA201007437B (en) Encapsulation of biologically active agents
IL207848A0 (en) Artificial enzymes
EP2035539A4 (en) Biogenerator constructed using live cell cultures
ZA201007498B (en) Encapsulation of biologically active agents
EP2386522A4 (en) Active oxygen generator
GB0814342D0 (en) Functionalised biologically active surfaces
GB0913796D0 (en) Functionalised biologically active surfaces
GB0817562D0 (en) Prepared active chart